Optune Lua is a wearable device for which tumor-treating fields (TTFields) inhibit the proliferation and metastasis of lung ...
Novocure announced on Tuesday that the FDA treated its Optune Lua wearable device for treating metastatic non-small cell lung ...
GlobalData on MSN21h
NovoCure scoops FDA approval on wearable for metastatic cancer treatmentOptune Lua received FDA approval based on data from the pivotal LUNAR trial which demonstrated significant median OS improvement.
Drug development in oncology is historically challenging, exhibiting a very high attrition rate, with low rates of approval for novel treatments when compared to other therapeutic areas. At present, ...
Investor's Business Daily on MSN15h
Intuitive Surgical's Earnings Are On Deck. Will Its 41% Surge Remain Intact?Intuitive Surgical stock is flirting with its 50-day line as the robotic surgery behemoth approaches its third-quarter report late Thursday.
Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback